Composition of test beverages (Table S1); primer set for amplification of the 16S rRNA genes of the gut microbiota (Table S2); genes differentially expressed during the experimental period (Table S3); pathway analysis for stress-responding genes in the placebo group at 1 day prior (Table S4); changed values of Shannon index in the stratified analysis of subjects with or without abdominal symptoms during the preintervention period (Table S5); changes in total and subscores of the GHQ-28 (Table S6); other questionnaires at the end of the trial (Table S7); changes in scores for each item in abdominal dysfunction (Table S8); changes in scores for each item in the GSRS (Table S9).
XLS, 70K